|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Subchronic oral toxicity studies with acyclodextrin in rats显示文摘 | Lina BA Bar A | 2004 | Regul Toxicol Pharmacol2004，39，1： | 1 |
| 2 | Isomaltulose ( palatinose ) :a review of biological and toxicological studies显示文摘 | Lina BA Jonker D Kozianowski G | 2002 | Food Chen Toxicol2002，40，10： | 1 |
| 3 | Isomaltulose (Palatinose):a review of biological and toxicological studies显示文摘 | Lina BA Jonker D Kozianowski G | 2002 | Food Chem Toxicol2002，40，10： | 1 |
| 4 | Isomaltulose (Palatinose):a review of biological and toxicological studies显示文摘 | LINA BA JONKER D KOZIANOWSKI G | 2002 | Food Chem Toxicol2002，40，10： | 1 |
| 5 | Isomaltulose (palatinose):a review of biological and toxicological studies显示文摘 | Jonker D Kozianowski G | 2002 | Food Chem Toxicol2002，40，10： | 1 |
| 6 | Isomaltulose (Palatinose): a review of biological and toxicological studies 显示文摘 | Lina BA Jonker D Kozianowski G | 2002 | Food Chem Toxicol2002，40，10： | 1 |
| 7 | Isomahulose (Palatinose) : a review of biological and toxicological studies显示文摘 | Lina BA Jonker D Kozianowski G | 2002 | Food Chem Toxicol2002，40，10： | 1 |
| 8 | Synthesis of Pyrene-based Planar Conjugated Polymers and the Regioisomers by Intramolecular Cyclization显示文摘Several planar conjugated polymers and model compounds containing pyrene units are synthesized.The pre-cursor polymers and model compounds are obtained through the Pd(0)-catalyzed Suzuki reaction,then the planar structure is formed through intramolecular cyclization in the presence of acid.We investigate the regioisomers in intramolecular cyclization reaction by using model compounds,suggesting that the syn-and anti-structures are formed in ladder-type polymer LP1,and the syn-structure is more easily formed in LP3.The planar conjugated polymers and model compounds show untypical features of ladder-type polymers,they display broad absorption and blue or blue-green emission in solution,and interchainπ-πstacking in film still occurs.Moreover,the new polymers and model compounds are characterized by nuclear magnetic resonance(NMR)spectroscopy,gel-permeation chromatography(GPC)and cyclic voltammetry(CV). | Xiaoyan Zhu Yonggang Wu Lina Zhou Yuan Wang Hongchi Zhao Baoxiang Gao Xinwu Ba | 2015 | Chinese Journal of Chemistry2015，33，4： | 0 |
| 9 | Effectiveness and safety of Jinshuibao capsules(金水宝胶囊)in treatment of residual cardiopulmonary symptoms in convalescent patients of coronavirus disease 2019:a pilot randomized,double-blind,placebo-controlled clinical trial显示文摘OBJECTIVE:To evaluate the effectiveness and safety of Jinshuibao capsules(金水宝胶囊),a Traditional Chinese Medicine(TCM),in the treatment of residual cardiopulmonary symptoms in convalescent corona virus disease 2019(COVID-19)patients.METHODS:A total of 200 participants with COVID-19 in convalescence phase were randomly assigned into two groups at a 1:1 ratio in this multicenter randomized,double-blind,placebo-controlled trial.One group received Jinshuibao capsules,and the other received placebo.The patients were followed up at one and two weeks of treatment.Five symptoms(dry cough,shortness of breath,sweating,chest tightness and palpitation)improvement rates and full recovery rates were compared.RESULTS:All baseline characteristics were comparable between the two groups.After two weeks of treatment,symptom improvement rates for dry cough(74.00%vs 50.00%,P=0.015),shortness of breath(78.95%vs 46.15%,P<0.001),sweating(80.00%vs 57.75%,P=0.004),chest tightness(87.06%vs 60.47%,P<0.001)and palpitation(82.50%vs 64.56%,P=0.010)were significantly higher in the Jinshuibao group compared with the control group.Meanwhile,Jinshuibao capsules treatment also displayed more satisfactory full recovery rates of all five symptoms(dry cough 58.00%vs 19.57%,shortness of breath 18.95%vs 7.69%,sweating 36.00%vs 19.72%,chest tightness 32.94%vs 13.95%,and palpitation 48.75%vs 29.11%)in participants with COVID-19 in convalescence phase compared with the control group(P<0.05).No severe adverse events were reported in either group.CONCLUSIONS:Jinshuibao capsules have the potential to improve residual cardiopulmonary symptoms in convalescent COVID-19 patients,with few adverse events. | ZHANG Yuehong DONG Dandan YAN Youqin ZHANG Hao WANG Guangli ZHOU Wei LI Wei QIU Li LI Tingming LIU Quan XIA Ping MAO Lina YANG Danlin YANG Lu LIAN Fengmei TONG Xiaolin BA Yuanming | 2023 | Journal of Traditional Chinese Medicine2023，43，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员